Bruker Announces Date and Time of Third Quarter 2022 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) will release its Q3 2022 financial results on November 3, 2022, before market opening. A conference call will follow at 8:30 a.m. ET to discuss the results and business trends. Investors can participate via webcast or telephone, with an option to pre-register for expedited entry. A replay of the call will be available until December 3, 2022. Bruker focuses on providing high-performance scientific instruments and solutions, enhancing research in life sciences and diagnostics.
- Upcoming Q3 2022 earnings call may provide positive insights on financial performance.
- Bruker's focus on high-value scientific instruments supports innovation and productivity.
- None.
To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q3 2022 Earnings Webcast” hyperlink in the “Events & Presentations” section. A slide presentation will be referenced during the webcast and will be posted to the Company’s website shortly before the webcast begins.
Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (
Bruker is enabling investors to pre-register for the earnings conference call so that they can expedite their entry into the call and avoid the need to wait for a live operator. In order to pre-register for the call, investors can visit https://dpregister.com/sreg/10172767/f4f381cd25 and enter their contact information. Investors will then be issued a personalized phone number and PIN to dial into the live conference call. Individuals can pre-register any time prior to the start of the conference call on
A telephone replay of the conference call will be available by dialing 1-877-344-7529 (
About
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221021005454/en/
Sr. Director, Investor Relations & Corporate Development
+1 (978) 663-3660 x1479
Investor.Relations@bruker.com
Source:
FAQ
When will Bruker Corporation report its Q3 2022 financial results?
What time is the Bruker earnings conference call?
How can I listen to Bruker's Q3 2022 earnings call?
What is the ticker symbol for Bruker Corporation?